Clinical trial
Multicenter Phase II Study for International Intraocular Retinoblastoma Classification Groups B, C & D Tumors Treated With Carboplatin-Etoposide-Vincristine-Cyclosporine-Focal Therapy Multimodality Protocol (OCRN Multicenter RB 2003)
NCT00110110 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Phase II Study for International Intraocular Retinoblastoma Classification Groups B, C & D Tumors Treated With Carboplatin-Etoposide-Vincristine-Cyclosporine-Focal Therapy Multimodality Protocol (OCRN Multicenter RB 2003)
- Lead sponsor
- The Hospital for Sick Children
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 30, 2004
- Completion date
- December 31, 2024
- Enrollment
- 71 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.